Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Research Hub

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 39.4 USD (-11.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -21.13, market cap 0.10B. This hub links to the full technical, earnings and options research available for COAG.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close39.4 USD (-11.46%)
52-week range24.55 USD – 55.18 USD
Trend regimeRange
14-day RSI25.5 (Oversold)
Trailing P/E-21.13
Market cap0.10B
Dividend yield0.00%
Next earnings2026-08-20

Available research for COAG

Earnings

COAG earnings: next report 2026-08-20, real EPS beat/miss history, analyst consensus Buy, P/E -21.13. Updated 2026-07-23.

Options: Covered Call

Covered Call on COAG: how it works, illustrative setup around the real 39.4 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on COAG: how it works, illustrative setup around the real 39.4 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on COAG: how it works, illustrative setup around the real 39.4 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

COAG technical analysis: range, last 39.4 USD, RSI 25.5, 52w range 24.55 USD–55.18 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is COAG in?

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is COAG in an uptrend or downtrend?

As of 2026-09-11, COAG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is COAG's trailing P/E ratio?

COAG's trailing P/E is -21.13, with a market cap of 0.10B. See the earnings research page for full valuation detail.

When does COAG next report earnings?

COAG is next scheduled to report earnings on 2026-08-20, with a consensus EPS estimate of -0.63 USD.